Citizens Business Bank Abb Vie Inc. Transaction History

Citizens Business Bank

$522 Million
Q4 2024

A detailed history of Citizens Business Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Citizens Business Bank holds 31,112 shares of ABBV stock, worth $6.29 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

31,112

Previous 31,779 2.1%

Holding current value

$6.29 Million

Previous $6.28 Million 11.9%

% of portfolio

1.06%

Previous 1.3%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $110,048 - $135,981	-667 Reduced 2.1%	31,112 $5.53 Million
Q3 2024 Nov 19, 2024	SELL	$163.84 - $199.33 $127,467 - $155,078	-778 Reduced 2.39%	31,779 $6.28 Million
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $2,129 - $2,591	13 Added 0.04%	32,557 $6.43 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $69,191 - $80,799	447 Added 1.39%	32,544 $5.58 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $78,151 - $89,046	-489 Reduced 1.5%	32,097 $5.84 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $377,024 - $424,617	-2,740 Reduced 7.76%	32,586 $5.05 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $187,827 - $217,437	-1,406 Reduced 3.83%	35,326 $5.27 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $154,374 - $192,108	1,165 Added 3.28%	36,732 $4.95 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $203,466 - $234,321	-1,407 Reduced 3.81%	35,567 $5.67 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $12,447 - $14,928	-90 Reduced 0.24%	36,974 $5.98 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $4.97 Million - $5.71 Million	37,064 New	37,064 $4.97 Million
Q2 2022 Nov 18, 2022	BUY	$137.62 - $174.96 $22,294 - $28,343	162 Added 0.25%	65,800 $10.1 Million
Q1 2022 Nov 18, 2022	SELL	$131.98 - $163.75 $776,834 - $963,832	-5,886 Reduced 8.23%	65,638 $10.6 Million
Q4 2021 Nov 18, 2022	SELL	$107.43 - $135.93 $46,624 - $58,993	-434 Reduced 0.6%	71,524 $9.69 Million
Q3 2021 Nov 18, 2022	SELL	$106.4 - $120.78 $8,724 - $9,903	-82 Reduced 0.11%	71,958 $7.76 Million
Q2 2021 Nov 18, 2022	BUY	$105.21 - $117.21 $23,777 - $26,489	226 Added 0.31%	72,040 $8.12 Million
Q1 2021 Nov 18, 2022	BUY	$102.3 - $112.62 $1.11 Million - $1.22 Million	10,848 Added 17.79%	71,814 $7.77 Million
Q4 2020 Nov 18, 2022	SELL	$80.49 - $108.67 $72,682 - $98,129	-903 Reduced 1.46%	60,966 $6.53 Million
Q3 2020 Nov 18, 2022	BUY	$85.91 - $100.83 $637,538 - $748,259	7,421 Added 13.63%	61,869 $5.42 Million
Q2 2020 Nov 18, 2022	BUY	$73.37 - $98.18 $683,588 - $914,743	9,317 Added 20.64%	54,448 $5.35 Million
Q1 2020 Nov 18, 2022	BUY	$64.5 - $97.79 $48,697 - $73,831	755 Added 1.7%	45,131 $3.44 Million
Q4 2019 Nov 18, 2022	SELL	$72.13 - $90.25 $81,579 - $102,072	-1,131 Reduced 2.49%	44,376 $3.93 Million
Q3 2019 Nov 18, 2022	SELL	$62.98 - $75.72 $40,055 - $48,157	-636 Reduced 1.38%	45,507 $3.45 Million
Q2 2019 Nov 18, 2022	SELL	$65.7 - $83.98 $54,333 - $69,451	-827 Reduced 1.76%	46,143 $3.36 Million
Q1 2019 Nov 18, 2022	SELL	$77.14 - $90.79 $1.07 Million - $1.26 Million	-13,883 Reduced 22.81%	46,970 $3.79 Million
Q4 2018 Nov 18, 2022	SELL	$77.85 - $96.01 $67,340 - $83,048	-865 Reduced 1.4%	60,853 $5.61 Million
Q3 2018 Nov 18, 2022	SELL	$88.91 - $98.84 $85,353 - $94,886	-960 Reduced 1.53%	61,718 $5.84 Million
Q2 2018 Nov 18, 2022	SELL	$89.78 - $106.23 $90,498 - $107,079	-1,008 Reduced 1.58%	62,678 $5.81 Million
Q1 2018 Nov 18, 2022	BUY	$92.01 - $123.21 $3,772 - $5,051	41 Added 0.06%	63,686 $6.03 Million
Q4 2017 Nov 18, 2022	SELL	$89.56 - $98.21 $35,017 - $38,400	-391 Reduced 0.61%	63,645 $6.16 Million
Q3 2017 Nov 18, 2022	SELL	$69.85 - $89.22 $221,913 - $283,451	-3,177 Reduced 4.73%	64,036 $5.69 Million
Q2 2017 Nov 18, 2022	BUY	N/A	30,149 Added 81.34%	67,213 $4.87 Million
Q1 2017 Nov 18, 2022	SELL	N/A	-3,700 Reduced 9.2%	36,532 $2.38 Million
Q4 2016 Nov 18, 2022	SELL	N/A	-9,496 Reduced 19.1%	40,232 $2.52 Million
Q3 2016 Nov 18, 2022	SELL	N/A	-1,751 Reduced 3.4%	49,728 $3.14 Million
Q2 2016 Nov 18, 2022	SELL	N/A	-1,900 Reduced 3.56%	51,479 $3.19 Million
Q1 2016 Nov 18, 2022	BUY	N/A	400 Added 0.76%	53,379 $3.05 Million
Q4 2015 Nov 18, 2022	SELL	N/A	-5,150 Reduced 8.86%	52,979 $3.14 Million
Q3 2015 Nov 18, 2022	SELL	N/A	-224 Reduced 0.38%	58,129 $3.16 Million
Q2 2015 Nov 18, 2022	SELL	N/A	-566 Reduced 0.96%	58,353 $3.92 Million
Q1 2015 Nov 18, 2022	BUY	N/A	4,597 Added 8.46%	58,919 $3.45 Million
Q4 2014 Nov 18, 2022	SELL	N/A	-5,070 Reduced 8.54%	54,322 $3.55 Million
Q3 2014 Nov 18, 2022	SELL	N/A	-709 Reduced 1.18%	59,392 $3.43 Million
Q2 2014 Nov 18, 2022	BUY	N/A	5,550 Added 10.17%	60,101 $3.39 Million
Q1 2014 Nov 18, 2022	BUY	N/A	22,349 Added 69.4%	54,551 $2.8 Million
Q3 2013 Nov 18, 2022	SELL	N/A	-920 Reduced 2.78%	32,202 $1.44 Million
Q2 2013 Nov 18, 2022	BUY	N/A	1,000 Added 3.11%	33,122 $1.37 Million
Q1 2013 Nov 18, 2022	SELL	N/A	-4,942	32,122 $1.31 Million

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Account

Citizens Business Bank Abb Vie Inc. Transaction History